Fresh2 Group (FRES) Competitors $0.85 0.00 (0.00%) As of 12/30/2024 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsSEC FilingsShort InterestTrends FRES vs. NTRA, LH, DGX, EXAS, RDNT, GH, VCYT, FTRE, VRDN, and CDNAShould you be buying Fresh2 Group stock or one of its competitors? The main competitors of Fresh2 Group include Natera (NTRA), Laboratory Co. of America (LH), Quest Diagnostics (DGX), Exact Sciences (EXAS), RadNet (RDNT), Guardant Health (GH), Veracyte (VCYT), Fortrea (FTRE), Viridian Therapeutics (VRDN), and CareDx (CDNA). These companies are all part of the "medical laboratories" industry. Fresh2 Group vs. Natera Laboratory Co. of America Quest Diagnostics Exact Sciences RadNet Guardant Health Veracyte Fortrea Viridian Therapeutics CareDx Fresh2 Group (NASDAQ:FRES) and Natera (NASDAQ:NTRA) are both multi-sector conglomerates companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk. Do insiders and institutionals have more ownership in FRES or NTRA? 0.5% of Fresh2 Group shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 26.2% of Fresh2 Group shares are held by insiders. Comparatively, 7.6% of Natera shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts rate FRES or NTRA? Natera has a consensus target price of $160.63, indicating a potential upside of 1.49%. Given Natera's higher possible upside, analysts clearly believe Natera is more favorable than Fresh2 Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fresh2 Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00Natera 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor FRES or NTRA? Natera received 481 more outperform votes than Fresh2 Group when rated by MarketBeat users. However, 100.00% of users gave Fresh2 Group an outperform vote while only 68.96% of users gave Natera an outperform vote. CompanyUnderperformOutperformFresh2 GroupOutperform Votes1100.00% Underperform VotesNo VotesNateraOutperform Votes48268.96% Underperform Votes21731.04% Which has more volatility & risk, FRES or NTRA? Fresh2 Group has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500. Which has stronger valuation & earnings, FRES or NTRA? Fresh2 Group has higher earnings, but lower revenue than Natera. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFresh2 Group$1.75M0.44-$14.77MN/AN/ANatera$1.08B19.30-$434.80M-$1.76-89.93 Does the media favor FRES or NTRA? In the previous week, Natera had 21 more articles in the media than Fresh2 Group. MarketBeat recorded 21 mentions for Natera and 0 mentions for Fresh2 Group. Natera's average media sentiment score of 0.65 beat Fresh2 Group's score of 0.00 indicating that Natera is being referred to more favorably in the news media. Company Overall Sentiment Fresh2 Group Neutral Natera Positive Is FRES or NTRA more profitable? Fresh2 Group has a net margin of 0.00% compared to Natera's net margin of -14.01%. Fresh2 Group's return on equity of 0.00% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Fresh2 GroupN/A N/A N/A Natera -14.01%-26.23%-14.27% SummaryNatera beats Fresh2 Group on 9 of the 17 factors compared between the two stocks. Get Fresh2 Group News Delivered to You Automatically Sign up to receive the latest news and ratings for FRES and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FRES vs. The Competition Export to ExcelMetricFresh2 GroupMedical laboratories IndustryMulti-Sector SectorNASDAQ ExchangeMarket Cap$765,000.00$2.98B$16.24B$9.15BDividend YieldN/A16.03%3.35%4.04%P/E RatioN/A15.3311.6917.34Price / Sales0.44201.062.28136.07Price / CashN/A426.0111.9535.97Price / BookN/A4.912.244.80Net Income-$14.77M-$33.85M$853.00M$224.91M7 Day PerformanceN/A1.75%1.17%1.76%1 Month Performance-31.15%-4.15%1.45%2.22%1 Year Performance-84.55%10.54%-10.51%20.65% Fresh2 Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FRESFresh2 GroupN/A$0.85flatN/AN/A$765,000.00$1.75M0.0075NTRANatera2.1892 of 5 stars$172.26+2.8%$153.67-10.8%+167.8%$22.74B$1.53B-97.883,293Analyst ForecastLHLaboratory Co. of America4.7364 of 5 stars$229.59+0.2%$258.62+12.6%+7.5%$19.20B$12.71B44.4167,000DGXQuest Diagnostics4.9682 of 5 stars$152.40+0.3%$172.15+13.0%+13.1%$17.01B$9.54B20.4848,000Ex-DividendAnalyst DowngradeShort Interest ↑News CoverageEXASExact Sciences4.7583 of 5 stars$57.80+1.0%$72.94+26.2%-23.6%$10.70B$2.69B-49.406,600News CoverageGap UpRDNTRadNet4.2986 of 5 stars$72.75+1.7%$84.75+16.5%+66.2%$5.39B$1.77B-1,039.1410,288Analyst ForecastNews CoverageGHGuardant Health3.4008 of 5 stars$35.88+6.3%$40.60+13.2%+58.4%$4.43B$692.26M-8.461,779Short Interest ↓VCYTVeracyte4.0778 of 5 stars$43.41+3.6%$41.13-5.3%+54.4%$3.36B$425.33M-289.40790Positive NewsFTREFortrea3.4787 of 5 stars$19.73+2.3%$23.30+18.1%-43.0%$1.77B$3.11B-5.7718,000Insider TradeShort Interest ↑VRDNViridian Therapeutics2.2258 of 5 stars$20.07-0.6%$35.70+77.9%-22.8%$1.59B$302,000.00-4.6650Short Interest ↑Positive NewsCDNACareDx3.711 of 5 stars$23.34+4.5%$29.60+26.8%+108.3%$1.25B$312.78M-8.64740Analyst ForecastShort Interest ↑Analyst Revision Related Companies and Tools Related Companies NTRA Alternatives LH Alternatives DGX Alternatives EXAS Alternatives RDNT Alternatives GH Alternatives VCYT Alternatives FTRE Alternatives VRDN Alternatives CDNA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FRES) was last updated on 1/17/2025 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresh2 Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresh2 Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
